These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 33219138)

  • 1. Association of Hippocampal Subfields, CSF Biomarkers, and Cognition in Patients With Parkinson Disease Without Dementia.
    Becker S; Granert O; Timmers M; Pilotto A; Van Nueten L; Roeben B; Salvadore G; Galpern WR; Streffer J; Scheffler K; Maetzler W; Berg D; Liepelt-Scarfone I
    Neurology; 2021 Feb; 96(6):e904-e915. PubMed ID: 33219138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation.
    Skouras S; Torner J; Andersson P; Koush Y; Falcon C; Minguillon C; Fauria K; Alpiste F; Blenow K; Zetterberg H; Gispert JD; Molinuevo JL;
    Brain; 2020 Mar; 143(3):976-992. PubMed ID: 32091109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).
    Nathan PJ; Lim YY; Abbott R; Galluzzi S; Marizzoni M; Babiloni C; Albani D; Bartres-Faz D; Didic M; Farotti L; Parnetti L; Salvadori N; Müller BW; Forloni G; Girtler N; Hensch T; Jovicich J; Leeuwis A; Marra C; Molinuevo JL; Nobili F; Pariente J; Payoux P; Ranjeva JP; Rolandi E; Rossini PM; Schönknecht P; Soricelli A; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB;
    Neurobiol Aging; 2017 May; 53():1-10. PubMed ID: 28189924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease.
    Skogseth RE; Bronnick K; Pereira JB; Mollenhauer B; Weintraub D; Fladby T; Aarsland D
    J Parkinsons Dis; 2015; 5(4):783-92. PubMed ID: 26599300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease.
    Foo H; Mak E; Chander RJ; Ng A; Au WL; Sitoh YY; Tan LC; Kandiah N
    Neuroimage Clin; 2017; 14():37-42. PubMed ID: 28116240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's Disease Biomarkers Have Distinct Associations with Specific Hippocampal Subfield Volumes.
    Müller-Ehrenberg L; Riphagen JM; Verhey FRJ; Sack AT; Jacobs HIL;
    J Alzheimers Dis; 2018; 66(2):811-823. PubMed ID: 30320590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.
    Cao J; Tang Y; Chen S; Yu S; Wan K; Yin W; Zhen W; Zhao W; Zhou X; Zhu X; Sun Z
    J Alzheimers Dis; 2024; 98(3):907-923. PubMed ID: 38489180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.
    Alves G; Brønnick K; Aarsland D; Blennow K; Zetterberg H; Ballard C; Kurz MW; Andreasson U; Tysnes OB; Larsen JP; Mulugeta E
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1080-6. PubMed ID: 20547614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson's disease.
    Low A; Foo H; Yong TT; Tan LCS; Kandiah N
    J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):681-687. PubMed ID: 30683708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of neuropsychological, neuroimaging, and cerebrospinal fluid markers predicts conversion from mild cognitive impairment to dementia.
    Eckerström C; Olsson E; Bjerke M; Malmgren H; Edman A; Wallin A; Nordlund A
    J Alzheimers Dis; 2013; 36(3):421-31. PubMed ID: 23635408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson's Disease.
    Oosterveld LP; Kuiper TI; Majbour NK; Verberk IMW; van Dijk KD; Twisk JWR; El-Agnaf OM; Teunissen CE; Weinstein HC; Klein M; Berendse HW; van de Berg WDJ
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF biomarkers and clinical progression of Parkinson disease.
    Hall S; Surova Y; Öhrfelt A; Zetterberg H; Lindqvist D; Hansson O
    Neurology; 2015 Jan; 84(1):57-63. PubMed ID: 25411441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do multiple system atrophy and Parkinson's disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study.
    Wang N; Zhang L; Yang H; Luo X; Fan G
    Eur Radiol; 2019 Sep; 29(9):4948-4956. PubMed ID: 30796577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's disease.
    La C; Linortner P; Bernstein JD; Ua Cruadhlaoich MAI; Fenesy M; Deutsch GK; Rutt BK; Tian L; Wagner AD; Zeineh M; Kerchner GA; Poston KL
    Neuroimage Clin; 2019; 23():101824. PubMed ID: 31054380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of cerebrospinal fluid Aβ
    Hu X; Yang Y; Gong D
    Neurol Sci; 2017 Nov; 38(11):1953-1961. PubMed ID: 28808876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.
    Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T
    Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Pagano G; De Micco R; Yousaf T; Wilson H; Chandra A; Politis M
    Neurology; 2018 Sep; 91(10):e894-e905. PubMed ID: 30089615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study.
    Zeng Q; Li K; Luo X; Wang S; Xu X; Li Z; Zhang T; Liu X; Fu Y; Xu X; Wang C; Wang T; Zhou J; Liu Z; Chen Y; Huang P; Zhang M;
    J Alzheimers Dis; 2021; 79(1):237-247. PubMed ID: 33252076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.